IP Library Granted Patent US 10,595,978
Granted Patent B2
US 10,595,978 · App. 15/423,625 · Granted Mar 24, 2020

System and method of laparoscopic use of hemostatic patch

Inventors: Kevin Lavigne (Hamden, CT); Steven Bennett (Cheshire, CT); Nathaniel Mast (Hamden, CT)
Assignee: Covidien LP
A61F2/0063A61L27/34A61L27/52A61L27/56A61B17/3468A61B2017/00287A61F2002/0072
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,595,978
App. No.
15/423,625
Granted
Mar 24, 2020
Kind
B2
Abstract

The present disclosure includes systems and a method for in situ application of a surgical patch during minimally invasive surgery. The method includes the steps of inserting a surgical patch into a bag; transferring a polymeric bag containing a hemostatic patch into a body cavity; removing the surgical patch from the polymeric bag while the polymeric bag is within the body cavity; and applying the surgical patch to a tissue within the body cavity.

Claims (26)

1. An apparatus for delivering a surgical patch into a body cavity during laparoscopic surgery, the apparatus comprising:

a surgical patch including a first hydrogel precursor and a second hydrogel precursor on the first hydrogel precursor, the first hydrogel precursor including one of nucleophilic functional groups or electrophilic functional groups, and the second hydrogel precursor including the other of the nucleophilic functional groups or the electrophilic functional groups, the first and second hydrogel precursors configured to react with one another to form a biocompatible cross-linked material; and

a polymeric bag,

the surgical patch disposed in the polymeric bag, the surgical patch and polymeric bag configured to be received within a deployment device for delivering the surgical patch and the polymeric bag into a body cavity.

2. The apparatus according to claim 1 , wherein the polymeric bag and the surgical patch are configured to be delivered together into the body cavity.

3. The apparatus according to claim 2 , wherein the surgical patch is selectively removable from the polymeric bag while the surgical patch and the polymeric bag are within the body cavity.

4. The apparatus according to claim 1 , wherein the surgical patch is configured to wick fluid for migration across the surgical patch to enable the first and second hydrogel precursors to react with one another.

5. The apparatus according to claim 1 , wherein the surgical patch is sealed inside the polymeric bag.

6. A system for performing a surgical procedure, the system comprising:

a polymeric bag;

a surgical patch within the polymeric bag, the surgical patch including a first hydrogel precursor and a second hydrogel precursor on the first hydrogel precursor, the first hydrogel precursor including one of nucleophilic functional groups or electrophilic functional groups, and the second hydrogel precursor including the other of the nucleophilic functional groups or the electrophilic functional groups, the first and second hydrogel precursors configured to react with one another to form a biocompatible cross-linked material; and

a deployment device including:

an elongated tube; and

a drive rod supported within the elongated tube and slidable to advance the polymeric bag and surgical patch along the elongated tube to dispense the polymeric bag and surgical patch from the elongated tube.

7. The system according to claim 6 , wherein the drive rod is connected to a spring.

8. The system according to claim 6 , wherein the drive rod includes a handle.

9. The system according to claim 6 , wherein the surgical patch comprises:

a substrate having the first hydrogel precursor applied to a first portion of the substrate; and

the second hydrogel precursor applied to a second portion of the substrate.

10. The system according to claim 9 , wherein the first and second hydrogel precursors are configured to react with one another to form a biocompatible cross-linked material while the surgical patch is positioned in a body cavity.

11. The system according to claim 10 , wherein the surgical patch is configured to wick fluid for migration across the surgical patch to enable the first and second hydrogel precursors to react with one another.

12. The system according to claim 6 , wherein the surgical patch is sealed inside the polymeric bag.

13. The system according to claim 6 , wherein the polymeric bag is constructed, at least in part, from polyurethane.

14. The system according to claim 6 , wherein the surgical patch is rolled or folded within the polymeric bag.

15. The system according to claim 9 , wherein the substrate is nonporous.

16. The system according to claim 9 , wherein the substrate is porous.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2017
From: LAVIGNE, KEVIN; BENNETT, STEVEN; MAST, NATHANIEL
To: CONFLUENT SURGICAL, INC.
Reel/Frame 041188/0309 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2017
From: CONFLUENT SURGICAL, INC.
To: COVIDIEN LP
Reel/Frame 041188/0343 →
Continuity (3)
Division 12791534 · Jun 1, 2010
Provisional Application 61229333 · Jul 29, 2009
Related Publication 20170143464A1 · May 25, 2017
Cited By (1)
US 12,629,445